Werewolf Therapeutics, Inc.
Clinical trials sponsored by Werewolf Therapeutics, Inc., explained in plain language.
-
New drug combo shows promise in early cancer trial
Disease control CompletedThis early-stage study tests a new drug called WTX-124, given alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. About 150 adults with certain…
Phase 1 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New cancer drug WTX-330 shows promise in early human trial
Disease control CompletedThis early-phase study tested a new drug called WTX-330 in 25 adults with advanced solid tumors or lymphoma that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink tumors. The study is now comp…
Phase 1 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC